Palatin Technologies Inc. Common Stock (PTN)
Stock · NASDAQ · Health Care
$10.48as of 8/28/2026
Price chart
Open in TradingViewActive signals
About PTN
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanot…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 29
- Website
- www.palatin.com/
Fundamentals
- 1-day range
- $9.65$11.11
- Market cap
- $14.64M
- P/E (trailing)
- 85.09
- P/E (forward)
- -4.31
- EPS (trailing)
- $-1.69
- Dividend yield
- —
- Beta
- 0.69
- Avg. volume
- 20.9K
How Palatin Technologies Inc. Common Stock Makes Money
Where the revenue actually goes — FY2024 annual results
Source: 10-K filed Sep 30, 2024 · via SEC EDGAR / Finnhub
Forecasts
3 analyst ratings
Palatin Technologies Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- PTNPalatin Technologies Inc. Common Stock$10.48▼ 0.10%Market cap $14.64MP/E 85.09$5.61$31
- AEONAEON Biopharma Inc. Class A Common Stock$0.3095▲ 5.27%Market cap $14.41MP/E —$0.1772$1.45
- KTTAPasithea Therapeutics Corp. Common Stock$0.5975▲ 7.66%Market cap $14.92MP/E —$0.281$2.06
- CYCNCyclerion Therapeutics Inc. Common Stock$3.81▼ 4.51%Market cap $15.11MP/E —$1.03$8.48
- KALAKALA BIO Inc. Common Stock$0.6949▼ 14.42%Market cap $15.14MP/E —$0.5867$1,030
- COCPCocrystal Pharma Inc. Common Stock$1.11▼ 2.63%Market cap $12.96MP/E —$0.76$2.67
- AKTXAkari Therapeutics plc ADS$11.03▲ 22.42%Market cap $12.88MP/E Infinity$3.02$49.6
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| PTN Palatin Technologies Inc. Common Stock | $14.64M | 85.09 | $10.48 | ▼ 0.10% | $5.61$31 |
| AEON AEON Biopharma Inc. Class A Common Stock | $14.41M | — | $0.3095 | ▲ 5.27% | $0.1772$1.45 |
| KTTA Pasithea Therapeutics Corp. Common Stock | $14.92M | — | $0.5975 | ▲ 7.66% | $0.281$2.06 |
| CYCN Cyclerion Therapeutics Inc. Common Stock | $15.11M | — | $3.81 | ▼ 4.51% | $1.03$8.48 |
| KALA KALA BIO Inc. Common Stock | $15.14M | — | $0.6949 | ▼ 14.42% | $0.5867$1,030 |
| COCP Cocrystal Pharma Inc. Common Stock | $12.96M | — | $1.11 | ▼ 2.63% | $0.76$2.67 |
| AKTX Akari Therapeutics plc ADS | $12.88M | Infinity | $11.03 | ▲ 22.42% | $3.02$49.6 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →- Arlene Morris · August 3, 2026 · Z2.4K
- Alan W. Dunton · August 3, 2026 · Z2.2K
- John K. A. Prendergast · August 3, 2026 · Z2.9K
- Stephen T. Wills · July 15, 2026 · Tax Withholding94 @ $14.34
- Stephen T. Wills · July 15, 2026 · Tax Withholding79 @ $11.72
- Stephen T. Wills · July 15, 2026 · Tax Withholding22 @ $11.77
- Carl Spana · July 15, 2026 · Tax Withholding142 @ $14.34
- Carl Spana · July 15, 2026 · Tax Withholding119 @ $11.72
- Carl Spana · July 15, 2026 · Tax Withholding33 @ $11.77
Institutional Ownership
March 31, 2026
- Total shares held
- 761.1K
- Total value held
- $13.26M
- Institutional holders
- 24
- Unknown166.7K
- Unknown140.0K
- Unknown140.0K
- Unknown70.0K
- Unknown61.9K
- Unknown41.2K
- Unknown36.0K
- Unknown27.3K
- Unknown19.0K
- Unknown18.5K
See the full, filterable feed with live charts on the MarketWall dashboard.